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Abstract
Background: Staphylococcus aureus is a major human pathogen, especially methicillin-resistant S.
aureus  (MRSA), which causes a wide range of hospital and community-acquired infections
worldwide. Conventional testing for detection of MRSA takes 2–5 days to yield complete
information of the organism and its antibiotic sensitivity pattern.
Results: The present study focused on the development of a pentaplex PCR assay for the rapid
detection of MRSA. The assay simultaneously detected five genes, namely 16S rRNA of the
Staphylococcus genus, femA of S. aureus, mecA that encodes methicillin resistance, lukS that encodes
production of Panton-Valentine leukocidin (PVL), a necrotizing cytotoxin, and one internal control.
Specific primer pairs were successfully designed and simultaneously amplified the targeted genes.
The analytical sensitivity and specificity of the pentaplex PCR assay was evaluated by comparing it
with the conventional method. The analytical sensitivity of the pentaplex PCR at the DNA level was
found to be 10 ng DNA. The analytical specificity was evaluated with 34 reference staphylococci
and non-staphylococcal strains and was found to be 100%. The diagnostic evaluation of MRSA
carried out using 230 clinical isolates, showed 97.6% of sensitivity, 99.3% of specificity, 98.8% of
positive predictive value and 98.6% of negative predictive value compared to the conventional
method. The presence of an internal control in the pentaplex PCR assay is important to exclude
false-negative cases.
Conclusion: The pentaplex PCR assay developed was rapid and gave results within 4 h, which is
essential for the identification of Staphylococcus spp., virulence and their resistance to methicillin.
Our PCR assay may be used as an effective surveillance tool to survey the prevalence of MRSA and
PVL-producing strains in hospitals and the community.
Published: 28 May 2009
BMC Microbiology 2009, 9:113 doi:10.1186/1471-2180-9-113
Received: 2 January 2009
Accepted: 28 May 2009
This article is available from: http://www.biomedcentral.com/1471-2180/9/113
© 2009 Al-Talib et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Microbiology 2009, 9:113 http://www.biomedcentral.com/1471-2180/9/113
Page 2 of 8
(page number not for citation purposes)
Background
Staphylococcus aureus is a facultative pathogenic Gram-pos-
itive bacterium that is well known as colonizer of the
human skin, and is a leading cause of diseases ranging
from mild skin and soft tissue infections to life-threaten-
ing illnesses, such as deep post-surgical infections, septi-
cemia and toxic shock syndrome [1]. Methicillin-resistant
S. aureus (MRSA) and methicillin-sensitive S. aureus
(MSSA) are responsible for a large proportion of nosoco-
mial infections, which makes treatment difficult [2]. Dur-
ing the past decade, an increasing number of MRSA cases
has been encountered globally among healthy commu-
nity residents [3]. These isolates are referred to as commu-
nity-acquired MRSA (CA-MRSA), which are genetically
and phenotypically different from representative hospital-
acquired MRSA (HA-MRSA), in relation to their antibiotic
resistance patterns, and by the allocation of their staphy-
lococcal chromosomal cassette (SCCmec) types, IV and V
[3,4]. Coagulase-negative staphylococci (CoNS) were
regarded as harmless skin commensals prior to the 1970s;
however, they are now recognized as important causes of
human infections [5,6]. CoNS are also among the most
commonly isolated bacteria in clinical microbiology lab-
oratories [7]. Furthermore, CoNS often serve as reservoirs
of antimicrobial-resistance determinants, since they usu-
ally have a high prevalence of multidrug resistance. There-
fore, it is important to describe and distinguish S. aureus
strains and CoNS [8]. Methicillin resistance in staphyloco-
cci is mainly mediated by the over-production of PBP2a,
an additional modified penicillin-binding protein with
low affinity for β-lactam antibiotics. The mecA gene, the
structural determinant that encodes PBP2a, is therefore
considered as a useful molecular marker of putative
methicillin resistance in S. aureus and CoNS [9,10].
Clinical laboratory tests for methicillin resistance are
highly dependent on growing conditions such as temper-
ature, pH and salt concentration [11]. Thus, these factors
emphasize the need to develop a rapid, accurate and sen-
sitive method for detection of methicillin-resistant sta-
phylococci, which does not depend on growth
conditions. Nucleic-acid-based tests using PCR are
increasingly being used in laboratories to replace time-
consuming, labor intensive and less sensitive conven-
tional diagnostic methods, such as biochemical identifica-
tion and Kirby-Bauer antimicrobial susceptibility tests.
Various PCR methods have been developed to identify: (i)
Staphylococcus genus [12]; (ii) methicillin-resistance [13];
and (iii) Panton-Valentine leukocidin (PVL)-producing
Staphylococcus genus [14]. These methods do not detect all
of the above-mentioned targets simultaneously. Hence,
the present study focused on the design of a pentaplex
PCR for methicillin-resistant staphylococci with an inter-
nal control for the detection of Staphylococcus genus (16S
rRNA gene), methicillin-resistant staphylococci (mecA
gene), community-acquired MRSA (lukS gene), and dis-
crimination between S. aureus and CoNS (femA gene).
Results
In the present study, the pentaplex PCR was optimized
successfully to identify the Staphylococcus  genus (16S
rRNA),  S. aureus species (femA), methicillin resistance
(mecA) and PVL toxin (lukS) genes simultaneously. Step-
wise optimization of primer concentration, annealing
temperature, MgCl2, dNTP and Taq polymerase was car-
ried out. The pentaplex PCR gave the best results when
3.13 mM MgCl2, 200 μM dNTP, 0.75 U Taq polymerase
and 60°C annealing temperature were used. The analyti-
cal sensitivity of the pentaplex PCR at the DNA level was
found to be 10 ng DNA (data not shown), whereas, at the
bacterial level, it was found to be 104 CFU/mL (data not
shown). The analytical specificity of the pentaplex PCR
assay at the genus level was determined using 10 staphy-
lococcal reference strains and found to be positive for the
Staphylococcus genus specific 16S rRNA gene. A represent-
ative gel picture of methicillin resistance with reference
strains is shown in Figure 1, while the other 10 Gram-pos-
itive non-staphylococcal and 13 Gram-negative strains
were negative. All the reference strains of S. aureus were
positive for femA gene by pentaplex PCR, while other
CoNS species were negative (Table 1). Hence, all methicil-
lin-resistant reference strains were positive for mecA gene
by pentaplex PCR. However, the methicillin-sensitive ref-
erence strains were negative for mecA gene by pentaplex
PCR (Table 1). Overall, the analytical specificity of penta-
plex PCR was 100% for the detection of MRSA reference
strains.
Upon completion of the standardization of the methicil-
lin-resistant pentaplex PCR assay with reference strains,
the assay was validated with 230 clinical isolates. Among
these, all had 16S rRNA, 82 contained mecA, 178 had femA
and none had lukS genes by pentaplex PCR. However, by
the conventional E-test antimicrobial susceptibility
method, 83 of the isolates were methicillin-resistant sta-
phylococci (oxacillin MIC ≥ 8 μg/mL). One of the S.
aureus isolates that was positive for mecA gene by penta-
plex PCR was found to be sensitive to oxacillin by the con-
ventional MIC method. The diagnostic accuracy of a
pentaplex PCR for 16S rRNA and femA genes was deter-
mined using 230 clinical isolates and found to have 100%
sensitivity, specificity, and positive and negative predic-
tive values. However, the pentaplex PCR for the mecA gene
detection showed 97.6% of sensitivity, 99.3% of specifi-
city, and 98.8% of positive and 98.6% of negative predic-
tive values in detecting methicillin-resistant
staphylococci.BMC Microbiology 2009, 9:113 http://www.biomedcentral.com/1471-2180/9/113
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Discussion
The present study is believed to be the first to develop a
combined molecular test for the rapid identification and
discrimination of the Staphylococcus  genus from others,
with simultaneous discrimination of methicillin-resistant
from -susceptible staphylococcal strains, S. aureus from
CoNS, and concomitant detection of PVL genes. Although
there are numerous reports on PCR assays for the detec-
tion of methicillin resistance [15-17], only a few of them
have incorporated internal controls in their assays to rule
out false-negative results [18,19]. According to guidelines
for Molecular Diagnostic Methods for Infectious Diseases
[20], incorporation of an internal control in the reaction
is essential for the diagnostic test to exclude false-negative
results or the presence of inhibitors [21]. In the present
study, the inclusion of a 759-bp internal control in the
pentaplex PCR assay helped us to rule out false-negative
results or PCR inhibitors. To deal with applicability and
accuracy, we further applied our pentaplex PCR assay to
test a total of 53 MRSA, 125 MSSA, 22 methicillin-sensi-
tive CoNS, and 30 methicillin-resistant CoNS from rou-
tine clinical specimens obtained from Hospital Universiti
Sains Malaysia.
The Staphylococcus genus consists of at least 35 unique spe-
cies, and only a few have been recovered from humans
[6]. Previously published staphylococcal genus specific
primers [22,23] do not target wholly conserved regions in
the staphylococcal 16S rRNA gene, which results in misde-
tection of some important CoNS. Therefore, we designed
a new conserved Staphylococcus genus-specific primer and
included it in our new pentaplex PCR assay, which
allowed us to detect most species and strains of staphylo-
cocci (Table 1). The pentaplex PCR was found to be 100%
sensitive and specific in detecting 16S rRNA genes among
staphylococcal strains.
Another gene, femA, has been characterized as essential for
the expression of methicillin resistance in S. aureus and is
universally present only in S. aureus isolates. This gene has
been implicated in cell wall metabolism and is present in
large amounts in actively growing cultures [24]. Specific
primers for femA were designed and used in the pentaplex
PCR to survey various staphylococcal isolates from our
culture collection. All 178 S. aureus cultures examined,
regardless of the presence or absence of mecA, produced a
positive result in PCR for femA. In contrast to the results
with S. aureus, when 52 strains of CoNS were examined
for the presence of the femA gene by pentaplex PCR, all
were negative. The femA gene in the pentaplex PCR assay
was able to rule out non-S. aureus staphylococci, as
reported by Francois et al. [25].
The mecA gene is unique to methicillin-resistant staphylo-
cocci [26]. The DNA sequences of the mecA genes found in
S. aureus and CoNS are >99% identical [27]. Thus, the
mecA gene represents a useful molecular component for
rapid identification of MRSA and methicillin-resistant
CoNS by PCR. One of the 147 MSSA isolates was shown
to be mecA-positive by pentaplex PCR. Although genotyp-
ically the mecA gene was detected and confirmed by PCR,
it is possible that the mecA gene is non-functional (non-
PBP-2a producing) and is not expressed phenotypically or
due to the presence of pseudogene [28]. Clinically, it is
important to differentiate between classical type mecA-
positive MRSA strains among other borderline-resistant S.
Pentaplex PCR assay profile with reference strains Figure 1
Pentaplex PCR assay profile with reference strains. M, 100-bp marker; lane 1, negative control; lane 2, Staphylococcal 
positive control; lane 3, ATCC 33591 (16S rRNA, femA-S. aureus, mecA); lane 4, ATCC 33592 (16S rRNA, femA-S. aureus, 
mecA); lane 5, ATCC 43300 (16S rRNA, femA-S. aureus, mecA); lane 6, ATCC 25923 (16S rRNA, femA-S. aureus, lukS); lane 7, 
ATCC 49775 (16S rRNA, femA-S. aureus, lukS); lane 8, ATCC 51153 (16S rRNA, femA-S. aureus); lane 9, CoNS methicillin-
resistant clinical isolate (16S rRNA, mecA); lane 10, ATCC 14990 (16S rRNA); lane 11, ATCC 29970 (16S rRNA); lane 12, 
ATCC 13518 (16S rRNA); M, 100-bp markerBMC Microbiology 2009, 9:113 http://www.biomedcentral.com/1471-2180/9/113
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aureus strains that result from hyperproduction of β-lacta-
mases [11].
The mecA-positive isolates were either heterogeneous or
homogeneous in their expression of resistance. When het-
erogeneous isolates are tested by standard conventional
methods, some cells appear susceptible and others resist-
ant, while almost all homogeneous isolates express resist-
ance when tested by standard methods [29].
Production of PBP-2a may be stimulated during chemo-
therapy with β-lactam antibiotics, which converts hetero-
geneous isolates into oxacillin-resistant strains, therefore,
the identification of methicillin-resistant staphylococci in
the laboratory is complicated by the heterogeneous nature
of the resistance, and by the variables that influence its
expression (i.e., medium, inoculum size, pH, tempera-
ture, and salt concentration) [30]. For these reasons,
detection of mecA gene is crucial for precise discrimina-
tion of methicillin resistance among staphylococci.
Almost 100% of CA-MRSA strains contain the lukS gene,
compared to <5% of HA-MRSA. The PVL-encoding gene
allows the production of a necrotizing cytotoxin, which
may be responsible for staphylococcal invasiveness and
virulence [4,31]. We included this gene in the pentaplex
PCR assay to categorize our isolates and accurately dis-
criminate CA-MRSA and HA-MRSA.
Table 1: Bacterial species and strains used in this study and results of pentaplex PCR.
No. Reference strains 16S rRNAa femA mecAb lukS Internal control
1. S. aureus (ATCC 33591) + + + - +
2. S. aureus (ATCC 33592) + + + - +
3. S. aureus (ATCC 43300) + + + - +
4. S. aureus (ATCC 25923)d ++ - + +
5. S. aureus (ATCC 49775) + + - + +
6. S. aureus (ATCC 51153)e ++ - - +
7. S. epidermidis (ATCC 14990) + - - - +
8. Staphylococcus haemolyticus (ATCC 29970) + - - - +
9. Staphylococcus saprophyticus (ATCC 13518)d +- - - +
10. CoNS methicillin-resistante +- + - +
11. Streptococcus spp. Group A (ATCC 19615)e -- - - +
12. Streptococcus spp. Group B (ATCC 12401)e -- - - +
13. Streptococcus spp. Group Ge -- - - +
14.Streptococcus spp. Group Fe -- - - +
15. Bacillus subtilis (ATCC 6633)e -- - - +
16.Listeria monocytogenes (ATCC 7644)e -- - - +
17. Enterococcus faecium LMG 16192c -- - - +
18. Enterococcus faecalis (ATCC 29212)e -- - - +
19. Corynebacterium sppe -- - - +
20. Escherichia coli (EHEC)e -- - - +
21. E. coli (EPEC)e -- - - +
22.E. coli (ETEC)e -- - - +
23. Klebsiella pneumoniae (ATCC 10031)e -- - - +
24. Shigella sonnei (ATCC 25931)e -- - - +
25. Shigella flexneri (ATCC 12022)e -- - - +
26. Shigella boydii (ATCC 9207)e -- - - +
27.Proteus mirabilis (ATCC 29245)e -- - - +
28. Salmonella typhie -- - - +
29. Pseudomonas aeruginosa (ATCC 27853)e -- - - +
30.Yersinia enterocolitica (ATCC 23715)e -- - - +
31. Vibrio cholerae (O1 classical)e -- - - +
32. Citrobacter freundii (ATCC 8090)e -- - - +
33.Gardnerella sppe -- - - +
34.Candida albicans (ATCC 10231)e -- - - +
a Staphylococcus genus
b methicillin-resistant genotype
c Reference strains from Belgian Co-ordinated Collections of Micro-organisms (BCCM), Ghent,
Belgium
d Obtained from Institute for Medical Research, Malaysia
e Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti
Sains Malaysia.BMC Microbiology 2009, 9:113 http://www.biomedcentral.com/1471-2180/9/113
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None of the MRSA, MSSA and CoNS isolates harbor the
PVL-encoding lukS gene. With regard to MRSA, this is not
surprising because all MRSA isolates in our study were
nosocomial organisms. A high prevalence of lukS gene
among MSSA has been reported in the neighboring coun-
tries of Singapore and Indonesia, with none and low prev-
alence of lukS gene among MRSA [32,33]. The low
prevalence in Malaysia is ascribed to restrictive antibiotic
usage and a strict policy of national surveillance for
MRSA.
Rapidly increasing prevalence of serious CA-MRSA infec-
tions and mortality have been reported globally [34-36],
an accurate and rapid method of screening S. aureus iso-
lates with lukS gene was a vital step for appropriate ther-
apy and controlling the dissemination of this potentially
virulent pathogen. In Malaysia, the presence of MRSA has
been reported [37,38], and cases of MRSA infection and
colonization have also been reported in the neighboring
countries of Singapore and Indonesia [32,33].
The presented pentaplex PCR assay is robust and practica-
ble for culture confirmation purposes. However, the 104
CFU/mL analytical sensitivity of this current pentaplex
PCR assay might not sensitive enough for the direct testing
of clinical specimens.
A previous study by Gosbell et al, in 2001 confirmed that
MRSA-screen test gave excellent sensitivity and specificity
for MRSA detection, and was quicker and cheaper than
PCR [39], while other study showed lower sensitivity and
specificity in detecting methicillin resistance in CoNS [40]
and couldn't identify neither PVL toxin encoding gene
among staphylococci nor differentiate between CA-MRSA
and HA-MRSA. Hence the PCR assay developed in the
present study will be useful in the epidemiological screen-
ing of MRSA patients or carriers. We are currently evaluat-
ing this assay for screening for MRSA carriage in Malaysia.
Conclusion
The PCR assay was able to detect four genes that are essen-
tial for the identification of S. aureus and its methicillin-
resistant genotypes simultaneously in a single test within
4 h. The built-in internal control in this assay prevented
false-negative results. The diagnostic accuracy was deter-
mined using 230 clinical specimens and showed 97.6% of
sensitivity and 99.3% of specificity in detecting methicil-
lin-resistant staphylococci. Hence, this test can be used as
an effective diagnostic and surveillance tool to monitor
the spread and emergence of MRSA.
Methods
Study design
This was a cross-sectional study in which the retrospective
sample size was calculated by using PS software (Dupont
& Plummer, 1997) using Dichotomous based on the sen-
sitivity of the E-test and PCR at 100% and 98% respec-
tively [41,42]. The Research and Ethics Committee,
School of Medical Sciences, Universiti Sains Malaysia,
approved the study protocol.
Bacterial strains and clinical specimens
The Staphylococcus spp. reference strains and other bacteria
used in this study are listed in Table 1. A total of 230 ret-
rospective Staphylococcus spp. that were isolated from rou-
tine clinical specimens obtained from Hospital Universiti
Sains Malaysia, from March 2006 to February 2007, were
used in this study. Among the 230 clinical isolates, 86
were from nasal samples, 45 from blood samples, 34 from
pus samples, 19 each from body fluid, wounds and CSF
samples, and eight from urine samples.
Screening of Staphylococcus spp. from clinical specimens 
by the conventional method
The clinical isolates were inoculated onto Columbia
blood agar (Merck, NJ, USA) plates with 5% sheep blood
for 24 h at 37°C. The staphylococcal isolates were identi-
fied morphologically and biochemically by standard lab-
oratory procedures [43]. The coagulase plasma test
(Remel, Lenexa, KS, USA) was performed on organisms
that exhibited typical staphylococcal colony morphology,
to allow for discrimination of S. aureus from CoNS. Sus-
ceptibility testing for methicillin resistance and other anti-
biotic resistance phenotypes was carried out by the Kirby-
Bauer methods [44]. MIC of methicillin was determined
by E-test kits (AB Biodisk, Solna, Sweden). The results
were categorized according to CLSI standards. Reference
strains used as controls were S. aureus (ATCC 33591), S.
aureus (ATCC 25923), and S. epidermidis (ATCC 12228)
(Table 1).
Primer design for pentaplex PCR assay
The 16S rRNA of Staphylococcus genus, and gene sequences
for femA, mecA and lukS of S. aureus were obtained from
GenBank [45], for DNA sequence alignment and primer
design. The ClustalW program in Vector NTI version 9.0
software (Invitrogen, Carlsbad, CA, USA) was used to
align the DNA sequences. The conserved and non-con-
served regions of the DNA sequence alignments were vis-
ualized using GeneDoc software [46].
Based on the conserved regions of the alignment, specific
primer pairs were designed to amplify the Staphylococcus
genus. Specific primers of S. aureus species were designed
based on the non-conserved regions of femA gene
sequences. Methicillin-resistance specific primers were
designed based on the conserved regions of mecA DNA
sequences. For the PVL-encoding gene, specific primers
were designed based on lukS gene. The five primer pairs
(Research Biolabs, KL, Malaysia) were designed in such aBMC Microbiology 2009, 9:113 http://www.biomedcentral.com/1471-2180/9/113
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way that the PCR products ranged from 151 to 759 bp.
The specificity of the designed primers was checked using
BLAST, which is available at the GenBank website [47].
The primer sequences for the five genes and expected PCR
product sizes are shown in Table 2. A primer pair based on
hemM gene was designed (759 bp) and was used as an
internal control (Table 2).
Pentaplex PCR assay
DNA-contamination is a major problem encountered in
the routine use of the PCR; we followed all contamination
prevention measures in the PCR daily work to avoid pre
and post-PCR contamination [48].
The monoplex PCR for each gene and the pentaplex PCR
assay were standardized using genomic DNA extracted
from reference Staphylococcus  spp. A mixture of DNAs
from two reference strains, namely S. aureus (ATCC
33591) and S. aureus (ATCC 25923), which contained the
four genes of interest was used as a positive control.
DNase-free distilled water was used as a negative control.
In addition, a plasmid pCR® 2.1-TOPO (Invitrogen) that
contained hemM gene (1 pg) was used as a template for
the internal control. To rule out false-negative results, an
internal control (primer pair and template) was incorpo-
rated in every reaction mixture including negative con-
trols.
Diagnostic evaluation of the pentaplex PCR was done
using the lysates from 230 clinical isolates. The isolated
colonies from blood agar were inoculated into LB broth
and incubated at 37°C for 24 h. Bacterial lysates for PCR
were prepared by centrifuging the 100 μl culture at 10,000
× g for 3 min; the supernatant was removed and the pellets
were resuspended in 100 μl DNase-free distilled water.
The suspensions were boiled in a water bath for 10 min
and centrifuged again at 10,000 × g for 3 min. Then, 2 μl
of the supernatants (lysates) was used in the pentaplex
PCR assays.
The optimized concentration of primer for each gene (0.6
pmol 16 S rRNA, 0.8 pmol femA S. aureus, 1.0 pmol mecA,
0.6 pmol lukS, and 0.8 pmol hemM) was used in the pen-
taplex PCR. The other components used in the PCR were
200 μM dNTPs, 3.13 mM MgCl2, 1× PCR buffer and 0.75
U Taq DNA polymerase (Fermentas, Vilnius, Lithuania).
The PCR was carried out using a Mastercycler Gradient
(Eppendorf, Hamburg, Germany) with one cycle of initial
denaturation at 94°C for 3 min, 30 cycles of denaturation
at 94°C for 30 s, annealing for 30 s at 60°C, and extension
at 72°C for 30 s, followed by an extra cycle of annealing
at 60°C for 30 s, and a final extension at 72°C for 5 min.
The PCR products were analyzed by electrophoresis on
1.5% low EEO agarose gels (Promega, Madison, WI,
USA), with ethidium bromide at 100 V for 75 min. PCR
products were visualized under UV illumination and pho-
tographed using an image analyzer (ChemiImager 5500;
Alpha Innotech, San Leandro, CA, USA).
Evaluation of pentaplex PCR assay
Analytical specificity was evaluated using DNA lysates pre-
pared from pure cultures of 10 phenotypically and geno-
typically well-characterized Staphylococcus  spp. and 10
non-staphylococcal Gram-positive and 13 Gram-negative
strains obtained from different sources (Table 1). The ana-
lytical sensitivity was evaluated using various concentra-
tions of genomic DNA starting from 1 μg to 10 pg and
lysate starting from 108 to 103 CFU/ml obtained from a
reference strain, S. aureus (ATCC 33591). The diagnostic
evaluation of the pentaplex PCR was carried out using 230
clinical isolates. The results were compared with the con-
ventional microbiological, biochemical, and antimicro-
bial susceptibility E-test which were considered as the
gold standard [20].
Table 2: Sequences of primers used for the pentaplex PCR.
Gene Primer Name 5'---------------------------------3' Gen Bank accession number Product size
Internal IC-F AGCAGCGTCCATTGTGAGA AF227752 759 bp
control hemM IC-R ATTCTCAGATATGTGTGG
16S rRNA 16S rRNA-F GCAAGCGTTATCCGGATTT D83356 597 bp
16S rRNA-R CTTAATGATGGCAACTAAGC
femA femA-F CGATCCATATTTACCATATCA CP000255 450 bp
femA-R ATCACGCTCTTCGTTTAGTT
mecA mecA-F ACGAGTAGATGCTCAATATAA NC_003923M 293 bp
mecA-R CTTAGTTCTTTAGCGATTGC
lukS lukS-F CAGGAGGTAATGGTTCATTT AB186917 151 bp
lukS-R ATGTCCAGACATTTTACCTAABMC Microbiology 2009, 9:113 http://www.biomedcentral.com/1471-2180/9/113
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Statistical analysis
The clinical sensitivity, specificity, and positive and nega-
tive predictive values of the pentaplex PCR were calculated
based on the CLSI Guidelines for Molecular Diagnostic
Methods for Infectious Diseases [20].
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